From July 9 to 11, 2025, Tokyo welcomed INTERPHEX Week, Japan's largest pharmaceutical and biotechnology exhibition, amid the midsummer heat. 

As a key exhibition of INTERPHEX, the Regenerative Medicine EXPO Tokyo has attracted many leading global companies in the industry.such as Thermo Fisher, Merck, and Asahi KASE, serving as a premier platform to showcase cutting-edge technologies and innovative achievements in the pharmaceutical sector.

Notably, The Regenerative Medicine EXPO Tokyo is the counterpart to the Regenerative Medicine EXPO Osaka, held in February.Following its participation in the Osaka exhibition, CHEMFISH returned to the Tokyo show, presenting high-end pharmaceutical intermediates and material chemical products to carve out a distinct niche with its unique product lineup.

During the exhibition, CHEMFISH reaped substantial gains. Beyond gathering valuable product insights, the company strengthened long-standing partnerships through face-to-face meetings with existing clients and expanded its market reach by forging connections with new customers, leveraging its resource advantages.

The Tokyo INTERPHEX Week provided CHEMFISH an outstanding platform to to connect with global pharmaceutical leaders and demonstrate its technological capabilities. Through active participation, the company not only enhanced its brand visibility but also made significant progress in the biopharmaceutical sector, marking a highly successful endeavor overall.